Characteristics and one-year follow-up of patients with peripheral arterial disease. Initial results of the COPART I registry;Caractéristiques et devenir à un an d'une cohorte de patients artériopathes hospitalisés : premiers résultats du registre COPART I

Annales de Cardiologie et d'Angeiologie

Volumn 56, Issue 2, 2007, Pages 74-81

  Vaysse, N ^a   Cambou, J P ^a   Labro, S ^a   Guilhem, J M ^a   Severac, D ^a   Boccalon, H ^a   Bura Riviere A ^a  

^a CHU RANGUEIL   (France)

Author keywords

Cohort; Critical limb ischemia; Intermittent claudication; One year follow up; Peripheral arterial disease; Registry

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; COURSE EVALUATION; DISEASE REGISTRY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTERMITTENT CLAUDICATION; LEG AMPUTATION; LEG ISCHEMIA; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; SAMPLE SIZE; SEX DIFFERENCE; SURGICAL MORTALITY; SURGICAL PATIENT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; AMPUTATION; COHORT ANALYSIS; FRANCE; ISCHEMIA; LEG; MORTALITY; PERIPHERAL VASCULAR DISEASE; REGISTER; VASCULARIZATION;

AGED; AMPUTATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; PERIPHERAL VASCULAR DISEASES; REGISTRIES;

EID: 33947326852     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2007.01.001     Document Type: Article

References (29)

1. Criqui M.H., Fronek A., et al. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
2. Newman A.B., Siscovick D.S., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88 (1993) 837-845
3. Hirsch A.T., Criqui M.H., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
4. Boccalon H., Lehert P., et al. Assessment of the prevalence of atherosclerotic lower limb arteriopathy in France as a systolic index in a vascular risk population. J. Mal. Vasc. 25 (2000) 38-46
5. Dormandy J.A., and Murray G.D. The fate of the claudicant--a prospective study of 1969 claudicant. Eur. J. Vasc. Surg. 5 (1991) 131
6. Belch J.F., Topol E.J., et al. Critical issues in peripheral disease detection and management. Arch. Intern. Med. 163 (2003) 884-892
7. Rossi E., Biasucci L.M., et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 105 7 (2002) 800-803
8. Cairo J., Migliaccio walle K., et al. The morbidity and mortality following a diagnosis of peripheral arterial disease : long term follow up of a large data base BMC Cardiovacular disorders (2005) 5-14
9. Criqui M.H., Langer R.D., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 326 6 (1992) 381-386
10. Jude E.B., Oyibo S.O., et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 24 8 (2001) 1433-1437
11. Luther M. The influence of arterial reconstructive surgery on the outcome of critical leg ischemia. Eur. J. Vasc. Surg. 8 (1994) 682
12. Dormandy J., Heeck L., et al. The fate of patients with critical leg ischemia. Semin. Vasc. Surg. 12 (1999) 142-147
13. Ebskov B. Relative mortality and long term survival for the non-diabetic lower limb amputee with vascular insufficiency. Prosthet. Orthot. Int. 23 (1999) 209-216
14. Kazmers A., Perkins A.J., et al. Major lower extremity amputation in Veterans Affairs medical centers. Ann. Vasc. Surg. 14 (2000) 216-222
15. Haute Autorité de Santé. Recommandations pour la pratique clinique. Prise en charge de l'artériopathie chronique oblitérante athéroscléreuse des membres inférieurs (indications médicamenteuses, de revascularisation et de rééducation) (2006), Argumentaire et Recommandations
16. Bhatt D.L., Steg P.G., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 2 (2006) 180-189
17. Feringa H.H., van Waning V.H., et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J. Am. Coll. Cardiol. 47 6 (2006) 1182-1187
18. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 9038 (1996) 1329-1339
19. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 9326 (2002) 7-22
20. Yusuf S., Sleight P., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342 3 (2000) 145-153
21. The I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Criticial Chronic Ischemia of the Lower Exremities." "Long-term mortality and its predictors in patients with critical leg ischaemia. Eur. J. Vasc. Endovasc. Surg. 14 2 (1997) 91-95
22. Hirsch A.T., Haskal Z.J., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 11 (2006) e463-e654
23. Ferrieres J., Cambou J.P., et al. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int. J. Cardiol. 112 3 (2006) 302-307
24. Vickrey B.G., Rector T.S., et al. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 33 4 (2002) 901-906
25. Mazoyer E., Drouet L., et al. Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude Thromb Res. 95 4 (1999) 163-176
26. Yan A.T., Yan R.T., et al. In-hospital revascularization and one-year outcomes of acute coronary syndrome patients stratified by the GRACE risk score. Am. J. Cardiol. 96 7 (2005) 913-916
27. Danchin N., Blanchard D., et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry. Circulation 110 (2004) 1909-1915
28. Dormandy J., Belcher G., et al. Prospective study of 713 below-knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. Hawaii Study Group. Br. J. Surg. 81 1 (1994) 33-37
29. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J. Vasc. Surg. 31 1 Pt 2 (2000) S1-S296